Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Gungl (Graz, Austria), V. Biasin (Graz, Austria), C. Slaven (Graz, Austria), L. Marsh (Graz, Austria), G. Kwapiszewska (Graz, Austria), H. Olschewski (Graz, Austria). Eosinophilic inflammation and worsening of lung function upon pirfenidone treatment in Fra-2 transgenic mice. 997

Member's Comments

No comment yet.

Related content which might interest you: Increased susceptibility to gammaherpesvirus-induced lung fibrosis of transgenic mice with conditional overexpression of the ER-stress-factor Chop in alveolar epithelium Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Nintedanib has acute pulmonary vasodilatory effects in transgenic Fra2 mice with spontaneous progressive pulmonary hypertension and lung fibrosis. Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Longterm NO2-exposure induces pulmonary inflammation and progressive development of airflow obstruction in C57BL/6 mice Source: Eur Respir J 2003; 22: Suppl. 45, 196s Year: 2003 Curcumin inhibits COPD-like airway inflammation and lung cancer promotion in mice Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 Bleomycin induced lung fibrosis in mice is attenuated by a new somatostatin analog Source: Annual Congress 2006 - Matrix remodelling at the interface of lung fibrosis and emphysema Year: 2006 Enhanced acute pulmonary inflammation and reduced fibrotic response in quartz-exposed p47phox-deficient mice Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Decreased Smad7 expression in the airways of a mouse model of chronic asthma Source: Annual Congress 2004 - Animal models of allergic airway disease Year: 2004 A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Effect of nintedanib on silica-induced lung inflammation and fibrosis in mice Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Enhanced expression of Robo4 ameliorates LPS-induced acute lung injury in mice Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Decreased peribronchial fibrosis in chronic ovalbumin-induced asthma model of PI3K deficiency mice Source: Eur Respir J 2005; 26: Suppl. 49, 26s Year: 2005 Effects of corticosteroid or montelukast associated to iNOS inhibitior on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2011 - Translational models of disease Year: 2011 FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice via decreasing MCP-1 mRNA Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Upregulated of NO-synthesising lung activity and its correction in LPS-induced lung injury in mice Source: Eur Respir J 2004; 24: Suppl. 48, 551s Year: 2004